Avvio Medical, Inc. (formerly Applaud Medical), a company dedicated to revolutionizing the treatment of urinary stones, today announced a bold step forward with a new name that reflects the Company’s vision for the future.

"Avvio is more than just a new name," stated Paul Molloy, President and Chief Executive Officer of Avvio Medical. "Meaning ‘start’, Avvio embodies the company’s unwavering dedication to propelling the future of kidney stone treatment. This name change signifies our commitment to bringing a novel technology, the AVVIO Acoustic Cavitation Lithotripsy System, to market and transforming the patient experience."

The AVVIO Acoustic Cavitation Lithotripsy System: A Paradigm Shift on the Horizon

The AVVIO Acoustic Cavitation Lithotripsy System utilizes low-pressure ultrasound waves to target patented AVVIO Microbubbles. The expansion and collapse of these microbubbles gently fragment urinary stones, offering an efficient, minimally invasive solution with the potential to:

• Eliminate the need for anesthesia and X-ray imaging in many cases
• Significantly expand treatment access, driving greater health equity
• Provide a more convenient and potentially less stressful experience for patients

About Avvio Medical

Avvio Medical is a privately held company which aims to improve treatment methods, patient experiences and medical costs for all patients experiencing the effects of urinary stones. The company’s initial technology is designed to offer patients and healthcare professionals a fast, minimally invasive solution for treating urinary stone disease in various clinical or outpatient settings, eliminating the routine need for anesthesia or X-ray imaging.

For more information, visit www.avviomed.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20240716533825/en/